1.Research advances on adrenergic receptor signaling involved in disease microenvironment through regulation of macrophages.
Ji-Ju WANG ; Da-Jin LI ; Mei-Rong DU
Acta Physiologica Sinica 2020;72(2):227-234
Adrenergic receptor (AR), one of the key receptors for nervous system, plays an important role in the immune microenvironment and the progression of many diseases. In recent years, the regulation of ARs and its signal on macrophages has become a research hotspot. Researchers found that ARs could exert different regulatory functions on macrophages in different microenvironments, which in turn affects occurrence and development of diseases such as tumor, heart failure, obesity, acute injury, infection and pregnancy-related diseases. This review summarizes the expression and functional regulation of ARs on macrophages, and the role of ARs in microenvironment of related diseases, which might provide new ideas for the treatments.
Disease
;
Humans
;
Macrophages
;
physiology
;
Receptors, Adrenergic
;
physiology
;
Signal Transduction
2.Updated roles of adrenergic receptors in prostate cancer.
Heng-Quan LUO ; Xiang-Xing KUANG ; Ben-Yi LI
National Journal of Andrology 2014;20(4):372-376
Adrenergic receptors are members of the G-protein coupled receptor superfamily. Recent studies revealed that these adrenergic receptors are playing an important role in the growth and metastasis of prostate cancer cells. The expression of adrenergic receptors rises significantly in prostate cancer cells and tissues. Agonists of these receptors promote the growth and mobility of prostate cancer cells, while antagonists may suppress their proliferation, trigger their apoptosis, and inhibit their metastasis. Clinically, receptor antagonists can significantly reduce the risk of prostate cancer and improve its prognosis after androgen depravation therapy. This article presents an overview on the roles of adrenergic receptors in prostate cancer.
Adrenergic Agonists
;
pharmacology
;
Adrenergic Antagonists
;
pharmacology
;
Apoptosis
;
Humans
;
Male
;
Prostatic Neoplasms
;
metabolism
;
pathology
;
Receptors, Adrenergic
;
drug effects
;
physiology
3.Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Ming ZHENG ; Qi-De HAN ; Rui-Ping XIAO
Acta Physiologica Sinica 2004;56(1):1-15
In the heart, stimulation of beta-adrenergic receptors (betaAR) serves as the most powerful means to increase cardiac contractility and relaxation in response to stress or a "fight-or-flight" situation. However, sustained beta-adrenergic stimulation promotes pathological cardiac remodeling such as myocyte hypertrophy, apoptosis and necrosis, thus contributing to the pathogenesis of chronic heart failure. Over the past decade, compelling evidence has demonstrated that coexisting cardiac betaAR subtypes, mainly beta(1)AR and beta (2)AR, activate markedly different signaling cascades. As a result, acute beta(1)AR stimulation activates the G(s) -adenylyl cyclase-cAMP-PKA signaling that can broadcast throughout the cell, whereas beta(2)AR-evoked cAMP signaling is spatially and functionally compartmentalized, due to concurrent G(i) activation. Chronic stimulation of beta(1)AR and beta(2)AR elicits opposing effects on the fate of cardiomyocytes: beta(1)AR induces hypertrophy and apoptosis; but beta(2)AR promotes cell survival. The cardiac protective effect of beta(2)AR is mediated by a signaling pathway sequentially involving G(i), G(betagamma), PI3K and Akt. Unexpectedly, beta(1)AR-induced myocyte hypertrophy and apoptosis are independent of the classic cAMP/PKA pathway, but require activation of Ca(2+)/calmodulin-dependent kinase II (CaMK II). The outcomes of cardiac-specific transgenic overexpression of either beta AR subtype in mice have reinforced the fundamentally different functional roles of these betaAR subtypes in governing cardiac remodeling and performance. These new insights regarding betaAR subtype stimulation not only provide clues as to cellular and molecular mechanisms underlying the beneficial effects of beta AR blockers in patients with chronic heart failure, but also delineate rationale for combining selective beta(1)AR blockade with moderate beta(2)AR activation as a potential novel therapy for the treatment of chronic heart failure.
Adenylyl Cyclases
;
metabolism
;
Animals
;
Cyclic AMP-Dependent Protein Kinases
;
metabolism
;
GTP-Binding Proteins
;
metabolism
;
Heart
;
physiology
;
Heart Failure
;
physiopathology
;
Humans
;
Myocardium
;
metabolism
;
Receptors, Adrenergic, beta
;
classification
;
physiology
;
Receptors, Adrenergic, beta-1
;
physiology
;
Receptors, Adrenergic, beta-2
;
physiology
;
Signal Transduction
4.alpha1-adrenoceptor antagonists and ejaculation dysfunction.
Yong CHEN ; Hong LI ; Qiang DONG
National Journal of Andrology 2008;14(4):364-367
alpha1-adrenoceptor antagonists are first-line agents for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia, while their adverse effects on sexual function are reported frequently in recent years, especially the induction of ejaculatory dysfunction. This review presents the distribution of alpha 1-adrenoceptors in the male genital system and the relationship of alpha1-adrenoceptors with ejaculatory function. It also highlights the interesting phenomenon of ejaculatory dysfunction related to these drugs and its possible mechanism, with the intention to provide some essential clues for further research on this problem as well as some references to safer use of these drugs in clinical settings.
Adrenergic alpha-1 Receptor Antagonists
;
Adrenergic alpha-Antagonists
;
adverse effects
;
pharmacology
;
Ejaculation
;
physiology
;
Erectile Dysfunction
;
chemically induced
;
physiopathology
;
Humans
;
Male
;
Receptors, Adrenergic, alpha-1
;
physiology
5.Electrophysiological effects of neurotransmitters on pacemaker cells in guinea pig left ventricular outflow tract.
Lan-Ping ZHAO ; Xiao-Yun ZHANG ; Yan-Jing CHEN ; Jian-Dong LI ; San-Ming ZHANG ; Xue-Fang WANG ; Fu-Gui GE
Acta Physiologica Sinica 2005;57(5):593-598
This study was designed to explore the innervation of autonomic nervous system and the distribution of receptors on pacemaker cell membrane in guinea pig left ventricular outflow tract (aortic vestibule). By using conventional intracellular microelectrode technique to record action potentials, autonomic neurotransmitters and antagonists were used to investigate the electrophysiological features and regularities of spontaneous activity of left ventricular outflow tract cells. Electrophysiological parameters examined were: maximal diastolic potential (MDP), amplitude of action potential (APA), maximal rate of depolarization (V(max)), velocity of diastolic depolarization (VDD), rate of pacemaker firing (RPF), 50% and 90% of duration of action potential (APD(50) and APD(90)). The results are listed below: (1) Perfusion with 100 mumol/L isoprenaline (Iso) resulted in a significant increase in V(max) (P <0.05), VDD, RPF, and APA (P <0.01), a notable decrease in MDP (P<0.05), and also a marked shortening in APD(50) (P<0.01). Pretreatment with Iso (100 mumol/L), propranolol (5 mumol/L) significantly decreased RPF and VDD (P<0.01), decreased APA, MDP and V(max) (P<0.01) notably, prolonged APD(50) (P<0.01) and APD(90) (P<0.05) markedly. (2) Application of 100 mumol/L epinephrine (E) resulted in a significant increase in VDD (P<0.05), RPF (P<0.001), V(max) (P<0.05) and APA (P<0.001), and a notable shortening in APD(50) and APD(90) (P<0.05). (3) Perfusion with 100 mumol/L norepinephrine (NE) led to a significant increase in VDD, RPF, APA and V(max) (P<0.05), and a marked shortening in APD(50) (P<0.05). Pretreatment with NE (100 mumol/L), phentolamine (100 mumol/L) significantly decreased RPF and VDD, MDP and APA (P<0.01), decreased V(max) notably (P<0.05), prolonged APD(50) and APD(90) markedly (P<0.01). (4) During perfusion with 10 mmol/L acetylcholine (ACh), VDD and RPF slowed down notably (P<0.05), APA decreased significantly (P<0.001), V(max) slowed down notably (P<0.01), APD50 shortened markedly (P<0.05), Atropine (10 mmol/L) antagonized the effects of ACh (10 mumol/L) on APD(50) (P<0.05). These results suggest that there are probably alpha-adrenergic receptor (alpha-AR), beta-adrenergic receptor (beta-AR) and muscarinic receptor (MR) on pacemaker cell membrane of left ventricular outflow tract in guinea pig. The spontaneous activities of left ventricular outflow tract cells are likely regulated by sympathetic and parasympathetic nerves.
Action Potentials
;
drug effects
;
Animals
;
Aorta, Thoracic
;
cytology
;
physiology
;
Electrophysiological Phenomena
;
Female
;
Guinea Pigs
;
Heart Ventricles
;
cytology
;
Male
;
Microelectrodes
;
Neurotransmitter Agents
;
physiology
;
Receptors, Adrenergic, alpha
;
physiology
;
Receptors, Adrenergic, beta
;
physiology
;
Receptors, Muscarinic
;
physiology
;
Ventricular Function, Left
;
physiology
6.Nitric oxide formation contributes to beta-adrenergic dilation of epicardial coronary arteries in response to intravenous administration of dobutamine in dogs.
Haoyi YANG ; Youbin DENG ; Xiaojun BI ; Qing CHANG ; Jiao BAI ; Min PAN ; Huijuan XIANG ; Hongyun LIU ; Xiulan LI ; Yani LIU ; Chunlei LI
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(2):189-191
To examine the role of nitric oxide in the beta-adrenergic vasodilation of epicardial coronary arteries in dogs, 12 dogs were instrumented for measurement of left anterior descending coronary artery diameter by transthoracic echocardiography before and after dobutamine (5 microg/kg/min IV) with and without intracoronary infusion of NG-monomethyl-L-arginine (L-NMMA) (1 mg/kg). In all 12 dogs, the diameter of left anterior descending coronary artery increased significantly from 2.35 +/- 0.25 mm to 2.59 +/- 0.24 mm (P<0.001) after dobutamine administration. In 6 of the 12 dogs, the percent change in left anterior descending coronary artery diameter induced by dobutamine decreased significantly from 12.5% +/- 8.6% to -1.5% +/- 5.4% (P<0.05) after the administration of intracoronary L-NMMA (1 mg/kg for 5 min) to block nitric oxide synthesis from L-arginine. The study demonstrated that nitric oxide formation contributes to the beta-adrenergic dilatory response of epicardial coronary arteries to dobutamine in dogs.
Adrenergic beta-Agonists
;
pharmacology
;
Animals
;
Coronary Vessels
;
physiology
;
Dobutamine
;
pharmacology
;
Dogs
;
Echocardiography
;
Female
;
Male
;
Nitric Oxide
;
physiology
;
Receptors, Adrenergic, beta
;
physiology
;
Vasodilation
;
physiology
;
omega-N-Methylarginine
;
pharmacology
7.New Frontiers in Pharmacology.
Yonsei Medical Journal 1979;20(2):87-91
8.Adrenergic sensitivity of uninjured C-fiber nociceptors in neuropathic rats.
Taick Sang NAM ; Dong Soo YEON ; Joong Woo LEEM ; Kwang Se PAIK
Yonsei Medical Journal 2000;41(2):252-257
We investigated the adrenergic sensitivity of afferent fibers in the L4 dorsal roots of rats with a unilateral ligation of the L5-L6 spinal nerves. About 12% of nociceptive fibers on the affected side were excited by sympathetic stimulation or by intra-arterial injection of norepinephrine which did not affect A beta-fiber activity. Sympathetic excitation of nociceptive fibers was suppressed by alpha 1-antagonist prazosin, while it was unaffected by alpha 2-antagonist yohimbine. Most of these fibers were excited by intra-arterial injection of alpha 1-agonist phenylephrine, without being affected by an injection of alpha 2-agonist clonidine. Sympathetic excitation was blocked by lidocaine applied near the receptive fields of recorded fibers. The results suggested that some nociceptors remaining intact after partial nerve injury become sensitive to sympathetic activity by the mediation of alpha 1-adrenoceptors in the peripheral endings.
Animal
;
Male
;
Nerve Fibers/physiology*
;
Nociceptors/physiology*
;
Norepinephrine/pharmacology
;
Pain/physiopathology*
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Adrenergic, alpha-1/physiology*
9.Role of beta-adrenergic signal transduction pathway on myocardial ischemic preconditioning of rats.
Xiaoli, LAN ; Jun, WANG ; Yongxue, ZHANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2005;25(6):709-11, 714
To study the changes in every part of the beta-adrenergic signal transduction pathway and their effects on ischemic preconditioning of rat myocardium in vivo. SD rats were divided into three groups: IP group, I/R group and CON group. The IP group was further divided into PC1-, 2-, 3-, and PC1+, 2+, 3+ groups according to preconditioning procedure. The rats received surgical procedure and underwent left coronary artery occlusion and reperfusion. We analyzed the infarct size by TTC staining, measured serum myocardial enzymes, studied the beta-AR Bmax and Kd by radioligand binding assay of receptors, checked the activity of AC and PKA by the method of biochemistry and examined the content of cAMP by radioimmunoassay. The infarct area was much smaller in the IP group than in the I/R group (P < 0.001), while the enzymes were significantly higher in I/R (P < 0.001). The Bmax of beta-AR in IP was much higher than that in I/R (P < 0. 001), but no difference in Kd could be seen between IP and I/R groups. In IP, the activity of AC and PKA and the content of cAMP were higher than those in I/R (P < 0.05, 0.002 and 0.001, respectively). In the procedure of preconditioning, the content of cAMP and the activity of PKA showed the characteristic of cyclic fluctuation. Ischemic preconditioning can protect the heart from necrosis and reduce endo-enzyme leakage. The system of beta-adrenergic signal transduction pathway probably takes part in the protection effect of the IP, which might be elicited by the PKA.
Ischemic Preconditioning, Myocardial
;
Myocardium/*metabolism
;
Rats, Sprague-Dawley
;
Receptors, Adrenergic, beta/*physiology
;
Signal Transduction
10.The Effect of Brimonidine on Transepithelial Resistance in a Human Retinal Pigment Epithelial Cell Line.
Jung Hyun PARK ; Sung Joon KIM ; Hyeong Gon YU
Korean Journal of Ophthalmology 2010;24(3):169-172
PURPOSE: To investigate the effects of brimonidine, an alpha-2-adrenergic agonist, on barrier function in ARPE-19 cells by measuring transepithelial resistance (TER). METHODS: ARPE-19 cells were cultured into a confluent monolayer on a microporous filter. Brimonidine was added to the apical medium, and the barrier function of the cells was evaluated by measuring TER. A subset of cells was treated under hypoxic conditions, and the TER changes observed upon administration of brimonidine were compared to those observed in cells in normoxic conditions. RESULTS: The ARPE cell membrane reached a peak resistance of 29.1+/-7.97 Omega cm2 after four weeks of culture. The TER of the cells treated under normoxic conditions increased with brimonidine treatment; however, the TER of the cells treated under hypoxic conditions did not change following the administration of brimonidine. CONCLUSIONS: Barrier function in ARPE-19 cells increased with brimonidine treatment. Understanding the exact mechanism of this barrier function change requires further investigation.
Adrenergic alpha-Agonists/*pharmacology
;
Cell Hypoxia/drug effects/physiology
;
Cell Line
;
Electric Impedance
;
Humans
;
Quinoxalines/*pharmacology
;
Receptors, Adrenergic, alpha-2/*drug effects
;
Retinal Pigment Epithelium/*drug effects/*physiology